SALT LAKE CITY, UT
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)THE CHOLANGIOCARCINOMA FOUNDATION, founded in 2006, is a community nonprofit in the Medical Research sector that reported $7.1M in total revenue in fiscal year 2024.
THE ORGANIZATION'S MISSION IS TO FIND A CURE AND IMPROVE THE QUALITY OF LIFE FOR CHOLANGIOCARCINOMA PATIENTS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $7,130,406 | $6,918,626 | +0.0% |
| Expenses | $7,195,778 | $6,237,924 | +0.2% |
| Net Income | $-65,372 | $680,702 | -1.1% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| STACIE LINDSEY | CEO/FOUNDER | 40.00 |
Officer
Director
|
$178,524 | $7,884 | $186,408 |
| LILY ZHANG | CFO | 40.00 |
Officer
|
$56,219 | $4,463 | $60,682 |
| MELINDA BACHINI | CPO | 40.00 |
Highest
|
$132,967 | $6,063 | $139,030 |
| JUAN VALLE | CHIEF MEDICA | 40.00 |
Highest
|
$227,510 | $15,529 | $243,039 |
| ALLI WARD | COO | 40.00 |
|
$143,957 | $3,624 | $147,581 |
| TERESA DELCORSO-ELLMANN | CHAIR | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| DANIEL BLUM | TREASURER | 2.50 |
Officer
Director
|
$0 | $0 | $0 |
| ROSS GREEN | BOARD MEMBER | 2.50 |
Director
|
$0 | $0 | $0 |
| JASON SCOTT | BOARD MEMBER | 2.50 |
Director
|
$0 | $0 | $0 |
| JACK CALLAWAY | BOARD MEMBER | 2.50 |
Director
|
$0 | $0 | $0 |
| LIZ WARNER | BOARD MEMBER | 2.50 |
Director
|
$0 | $0 | $0 |
| TYLER BRIDEGAN | BOARD MEMBER | 2.50 |
Director
|
$0 | $0 | $0 |
| KRIS HIGH | BOARD MEMBER | 2.50 |
Director
|
$0 | $0 | $0 |
| JERRY HUANG | BOARD MEMBER | 2.50 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $7,130,406 | $7,195,778 | $5,767,836 | $-65,372 |
| 2024 | $6,918,626 | $6,237,924 | $5,980,953 | $680,702 |
| 2023 | $5,082,650 | $5,266,027 | $4,624,165 | $-183,377 |
| 2022 | $4,935,665 | $3,620,452 | $4,018,118 | $1,315,213 |
| 2021 | $3,901,961 | $2,279,422 | $2,743,945 | $1,622,539 |
| 2020 | $1,887,741 | $1,782,307 | $1,219,709 | $105,434 |
| 2019 | $2,209,603 | $1,933,077 | $815,602 | $276,526 |
| 2018 | $1,527,321 | $1,289,062 | $699,116 | $238,259 |
Compare THE CHOLANGIOCARCINOMA FOUNDATION with other nonprofits in Utah and across the country.